132 related articles for article (PubMed ID: 4406343)
21. Tardive dyskinesias from the major tranquilizers.
Thornton WE; Thornton BP
JFMA; 1973 Sep; 60(9):24-6. PubMed ID: 4732351
[No Abstract] [Full Text] [Related]
22. Interaction between barbiturates, alcohol and some psychotropic drugs.
Milner G
Med J Aust; 1970 Jun; 1(24):1204-7. PubMed ID: 5451395
[No Abstract] [Full Text] [Related]
23. Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.
Turek I; Kurland AA; Hanlon TE; Bohm M
Br J Psychiatry; 1972 Dec; 121(565):605-12. PubMed ID: 4648433
[No Abstract] [Full Text] [Related]
24. Tardive dyskinesia treated with pimozide.
Claveria LE; Teychenne PF; Calne DB; Haskayne L; Petrie A; Pallis CA; Lodge-Patch IC
J Neurol Sci; 1975 Apr; 24(4):393-401. PubMed ID: 235013
[TBL] [Abstract][Full Text] [Related]
25. Single phenothiazines and tardive dyskinesia.
Yassa R; Dimitry R
J Clin Psychiatry; 1983 Jun; 44(6):233-4. PubMed ID: 6853464
[No Abstract] [Full Text] [Related]
26. Persistence of neurological symptoms due to neuroleptic drugs.
Crane GE
Am J Psychiatry; 1971 Apr; 127(10):1407-10. PubMed ID: 5549937
[No Abstract] [Full Text] [Related]
27. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
Gurovich IIa; Fleĭs EP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
[No Abstract] [Full Text] [Related]
28. Sudden death in phenothiazine therapy. (A clinicopathologic study of 12 cases).
Moore MT; Book MH
Psychiatr Q; 1970; 44(3):389-402. PubMed ID: 5514886
[No Abstract] [Full Text] [Related]
29. Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
Chase TN; Schnur JA; Gordon EK
Neuropharmacology; 1970 May; 9(3):265-8. PubMed ID: 5424003
[No Abstract] [Full Text] [Related]
30. Tardive dyskinesia: an evaluation of the etiologic association with neuroleptic therapy.
Baldessarini RJ
Can Psychiatr Assoc J; 1974 Dec; 19(6):551-4. PubMed ID: 4613452
[No Abstract] [Full Text] [Related]
31. Paradoxical effects of phenothiazines.
Seeman MV; Denber HC; Goldner F
Psychiatr Q; 1968; 42(1):90-103. PubMed ID: 4384921
[No Abstract] [Full Text] [Related]
32. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
Rubovits R; Klawans HL
Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718
[No Abstract] [Full Text] [Related]
33. Motor disorders induced by neuroleptics: a proposed new classification.
Crane GE; Naranjo ER
Arch Gen Psychiatry; 1971 Feb; 24(2):179-84. PubMed ID: 4924291
[No Abstract] [Full Text] [Related]
34. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.
Crane GE
Am J Psychiatry; 1968 Feb; 124(8):Suppl:40-8. PubMed ID: 4865731
[No Abstract] [Full Text] [Related]
35. Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia.
Bullock RJ
Med J Aust; 1972 Aug; 2(6):314-6. PubMed ID: 4404280
[No Abstract] [Full Text] [Related]
36. The extrapyramidal neuroleptic syndrome: description and measurement.
Elie R; Gagnon MA; Lamontagne Y; Tetreault L
Curr Ther Res Clin Exp; 1973 Jul; 15(7):427-40. PubMed ID: 4198304
[No Abstract] [Full Text] [Related]
37. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
Elie R; Morin L; Tétreault L
Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
[No Abstract] [Full Text] [Related]
38. [On the question of possible irreversible disorders due to psychopharmacotherapy].
Meyer HH
Arch Psychiatr Nervenkr (1970); 1966; 208(4):345-59. PubMed ID: 5969585
[No Abstract] [Full Text] [Related]
39. Pseudoparkinsonism and tardive dyskinesia.
Crane GE
Arch Neurol; 1972 Nov; 27(5):426-30. PubMed ID: 5078897
[No Abstract] [Full Text] [Related]
40. Is tardive dyskinesia a drug effect?
Crane GE
Am J Psychiatry; 1973 Sep; 130(9):1043-4. PubMed ID: 4727768
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
